Literature DB >> 9807231

Efficacy of the Substance Abuse Subtle Screening Inventory-3 (SASSI-3) in identifying substance dependence disorders in clinical settings.

L E Lazowski1, F G Miller, M W Boye, G A Miller.   

Abstract

This article presents analyses on psychometric properties of a recent revision of the Substance Abuse Subtle Screening Inventory (SASSI-3). Participants were 772 individuals from a range of clinical settings who were independently diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders (3rd ed., rev. [DSM-III-R]; American Psychiatric Association [APA], 1987) or DSM-IV (APA, 1994) criteria regarding the presence or absence of a substance-dependence disorder. A development sample (n = 391) was used to formulate SASSI-3 decision rules that yielded 95% agreement with clinical diagnoses of substance dependence. Correspondence with the criterion variable was shown to be 97% in a cross-validation sample (n = 381) from the same clinical settings. Convergent relations were demonstrated with a variety of other indexes of substance misuse, including clinical assessments of substance abuse history, alcohol and drug-related arrests, self-reported use of illicit drugs, and other instruments designed to screen for substance misuse. Further, logistic regression analyses indicated no significant differences in the overall accuracy of the SASSI-3 as a function of respondents' demographic characteristics or clinical ratings of respondents' level of adjustment and functioning (Global Assessment of Functioning ratings; APA, 1987, 1994).

Entities:  

Mesh:

Year:  1998        PMID: 9807231     DOI: 10.1207/s15327752jpa7101_8

Source DB:  PubMed          Journal:  J Pers Assess        ISSN: 0022-3891


  7 in total

1.  Use of the adolescent SASSI in a juvenile correctional setting.

Authors:  L A R Stein; Rebecca Lebeau-Craven; Rosemarie Martin; Suzanne M Colby; Nancy P Barnett; Charles Golembeske; Joseph V Penn
Journal:  Assessment       Date:  2005-12

2.  Co-morbidity of substance use disorder and psychopathology in women who use methamphetamine during pregnancy in the US and New Zealand.

Authors:  Trecia A Wouldes; Linda L LaGasse; Chris Derauf; Elana Newman; Rizwan Shah; Lynne M Smith; Amelia M Arria; Marilyn A Huestis; Sheri DellaGrotta; Tara Wilcox; Charles R Neal; Barry M Lester
Journal:  Drug Alcohol Depend       Date:  2012-07-11       Impact factor: 4.492

3.  Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later.

Authors:  Bertha K Madras; Wilson M Compton; Deepa Avula; Tom Stegbauer; Jack B Stein; H Westley Clark
Journal:  Drug Alcohol Depend       Date:  2008-10-16       Impact factor: 4.492

4.  Psychiatric consultation and substance use disorders.

Authors:  Sheila Specker; William H Meller; Steven Thurber
Journal:  Subst Abuse       Date:  2009-11-27

5.  Reports of past alcohol and drug use following participation in a motivation enhancing intervention: implications for clinical assessment and program evaluation.

Authors:  David B Rosengren; Blair Beadnell; Mark Nason; Pamela A Stafford; Ray Daugherty
Journal:  Subst Abuse Treat Prev Policy       Date:  2012-05-14

6.  SASSI: a reply to the critique of Feldstein & Miller (2007).

Authors:  Linda E Lazowski; Glenn A Miller
Journal:  Addiction       Date:  2007-06       Impact factor: 6.526

7.  Neural correlates of working memory training in HIV patients: study protocol for a randomized controlled trial.

Authors:  L Chang; G C Løhaugen; V Douet; E N Miller; J Skranes; T Ernst
Journal:  Trials       Date:  2016-02-02       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.